Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance

Figures & data

Figure 1 NHS Trusts in the UK that responded to the electronic survey. Centres are colour coded according to the number of patients reported to be under primary hepatocellular carcinoma (HCC surveillance).

Table 1 Comparison Between HPB Centres and Non-HPB Centres

	All (n=39) Median (Range)	HPB Centres (n=15) Median (Range)	Non-HPB Centres (n=24) Median (Range)	p value
Number of consultants	5 (2–19)	8 (3–15)	4 (1–15)	0.03
Number of CNS	3 (0–13)	2 (0–10)	1.5 (0–5)	0.12
Patients on HCC surveillance	700 (100–3000)	1250 (300–3000)	500 (100–1250)	0.38
Patient/consultant ratio	150 (28–750)	156 (27–750)	145 (43–500)	0.89
Patient/CNS ratio	150 (83–1500)	140 (60–1500)	233 (54–1250)	0.20

Abbreviations: CNS, clinical nurse specialists; HCC, hepatocellular carcinoma; HPB, hepato-pancreato-biliary.

Table 2 Comparison Between HCC Surveillance Practice in 2014¹⁴ and in 2021 (Current Study)

	2014	2021
Centres responded	84%	49%
Proportion of non-HPB centres	58%	62%
Consultant staffing (median, range)	4 (1–10)	5 (2–19)
Centres with an established US HCC surveillance programme	97%	92%
Verbal/written explanation given to patient	71%	92%
Non-specialist radiographers/radiologists performing surveillance scans	77%	79%
Automatic request of additional diagnostic scan if abnormality detected	9%	3%
Regular audit of HCC surveillance programme	8%	13%

Abbreviations: HCC, hepatocellular carcinoma; HPB, hepato-pancreato-biliary; US, ultrasound scan.

Cross TJS, Villanueva A, Shetty S, et al. A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma. Frontline Gastroenterol. 2016;7(2):82–89. doi:10.1136/flgastro-2015-100617

 PubMedGoogle Scholar